Fri, 8th Mar 2019 14:30
Indivior PLC - Directorate Change
Indivior PLC announces that Dr. Yvonne Greenstreet, Non-Executive Director, has confirmed that she will retire from the Board with effect from March 31, 2019. As announced in November 2018, Dr. Greenstreet had already advised that she would not seek re-appointment at the Company's 2019 AGM.
The Board has reviewed its composition and that of its Committees and confirms that it has no current plans to recruit a successor to Dr. Greenstreet. Tom McLellan will be appointed Chair of the Science & Policy Committee with effect from March 31, 2019. Dr. McLellan has served as a Member of the Science & Policy Committee since his appointment as a Non-Executive Director in November 2014.
Howard Pien, Chair of Indivior, commented:
'Yvonne has served as a Non-Executive Director since the Company's listing on the London Stock Exchange in 2014 and has been Chair of the Science & Policy Committee and a member of the Audit Committee throughout her tenure. I would like to thank Yvonne for her exemplary contribution to the Company. The Board and I wish her well for the future.
We are pleased to appoint Tom McLellan as Chair of the Science & Policy Committee. Tom's extensive experience in the field of addiction spans more than 35 years as a career researcher in the treatment and policy-making around substance use and abuse and makes him a natural successor as Committee Chair.'
This announcement is made pursuant to Listing Rule 9.6.11(2).
No remuneration is payable consequent upon or in respect of Yvonne Greenstreet's retirement. She will receive pro-rated Board fees and Audit Committee and Science & Policy Committee fees, as applicable, to the date of her retirement. She will not receive any payment for loss of office or any other payments in relation to her retirement.
Kathryn Hudson, Company Secretary
Tel: +44 (0)1753 423940